US Stock MarketDetailed Quotes

SYRS Syros Pharmaceuticals

Watchlist
  • 0.2600
  • -0.0300-10.34%
Close Nov 21 16:00 ET
  • 0.2687
  • +0.0087+3.35%
Post 20:01 ET
6.98MMarket Cap-84P/E (TTM)

Syros Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Syros Pharmaceuticals Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
360.00K
0
-360.00K
Miss Est.
-90.43%
-100.00%
-100.00%
EPS
-0.68
-0.16
+0.52
Beat Est.
+52.73%
+88.81%
+76.33%
Analyst Rating
Buy

Nov 21, 2024

Syros Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 450.000K--
Oct 31, 20242024/Q30.000 / 360.000K--
Jul 31, 20242024/Q20.000 / 460.000K--
May 14, 20242024/Q10.000 / 720.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 450.000K--
Oct 31, 20242024/Q30.000 / 360.000K--
Jul 31, 20242024/Q20.000 / 460.000K--
May 14, 20242024/Q10.000 / 720.000K--

Unlock Free Earnings Estimates

Syros Pharmaceuticals Earnings Reports

  • Syros Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Oct 31 18:52

  • Syros Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Jul 31 19:00

  • Syros Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 14 18:44

  • Syros Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 27 18:54

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Buy

    • Buy

      40.00%

    • Hold

      60.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data